This is BrainsWay’s global website. The website includes information on clinical indications that were not cleared by the FDA and are considered investigational by the U.S. medical device regulations. The FDA cleared BrainsWay D treatment of Major Depression in patients who failed to respond to one or more anti-depressants in the current episode.
Karen Sarid
Karen Sarid
Ms. Sarid is a business oriented senior executive with over 30 years of operation, sales, financial and strategic experience in international hi-tech companies.
Received at the end of 1998 the award of the CFO of the year in Israel of the CFO organization and the head of economic activities in Israel.
Major Achievements
- Sale of Alma Lasers to Fosun Pharma (2013)
- Acquisition of Quantel Darma Assets by Alma Lasers (2012)
- Negotiations for the merger of Galil Medical and Endocare (2009)
- Sale of Orex Computed Radiography to the Medical Division of Kodak
- Acquisition of Lasers Industries by ESC Medical (1998)
- Convertible bonds issuance of ESC Medical, the first convertible bonds issuance by an Israeli company in NASDAQ (1997)
- Secondary public offering by ESC Medical in NASDAQ (1996)
Experience
01/14 – present – chairman of Hairstetics
01/17 – present – board member of Cherry Imaging.
03/14 – 7/17 – Syneron Medical Ltd.
VP Beauty and Dental , Chairman of China activities. Focus on the strategic actives of Syneron in China , expanding its activities in China. Manage the company’s dental business, including sales, marketing and operations. Sold the dental Business to a Chinese organization. Responsible for building the company’s beauty business including initiating strategic alternatives.
01/14- Present Chairman of Hairstetics- a private company in the field of hair implant , funded by Potifax and Generally.
01/12 – 08/13 – Alma Lasers Ltd.
President. Responsible for the strategic alternatives of the company. Initiate the sale of the company and managed the entire process including identifying strategic and financial acquirers, the due diligence process and negotiations.
01/13 – 8/16 Director at MCS , member of the audit and compensation committee.
06/09 – 10/10 – Syneron Medical Ltd.
General Manager of Syneron in Israel. In addition to managing the Israeli site, responsible for the Dental Division as well as the joint venture in China. Started the home use activity of Syneron as well as the skin whiting activities.
05/09: Galil Medical Ltd.